Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
grc 17356 (1 trial)
Diabetic Neuropathies (Phase 2)
Pain (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Trials (1 total)
Trial APIs (1 total)